A Technical Analysis
As of date:2/26/2020
A stock price:78.11
A 50 DMA:85.32
A 200 DMA:76.21
A MACD (200-50):-9.11
A RSI:27.30
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)27.30
Extremely
Oversold

Also see:
A Market Cap History
A Shares Outstanding History
A YTD Return

Quotes delayed 20 minutes
Get Free SEC filing alerts for A:
A SEC Filing Email Alerts ServiceExternal link

Notable Two Hundred Day Moving Average Cross - WOW
37 minutes ago


VRS Crosses Below Key Moving Average Level
37 minutes ago


MGM Growth Properties Breaks Below 200-Day Moving Average - Notable for MGP
37 minutes ago


ENIC Makes Notable Cross Below Critical Moving Average
37 minutes ago


Hertz Global Holdings (HTZ) Shares Cross Below 200 DMA
37 minutes ago


GTES Crosses Below Key Moving Average Level
37 minutes ago


Summit Materials (SUM) Shares Cross Below 200 DMA
1 hour ago


Notable Two Hundred Day Moving Average Cross - MSG
1 hour ago


Ferrari Breaks Below 200-Day Moving Average - Notable for RACE
1 hour ago


Notable Two Hundred Day Moving Average Cross - ATEN
1 hour, 3 minutes ago


Science Applications International (SAIC) Shares Cross Below 200 DMA
1 hour, 6 minutes ago


Third Point Reinsurance (TPRE) Shares Cross Below 200 DMA
1 hour, 8 minutes ago


Notable Two Hundred Day Moving Average Cross - EVRI
1 hour, 13 minutes ago


KMI Makes Notable Cross Below Critical Moving Average
1 hour, 14 minutes ago


Douglas Dynamics (PLOW) Shares Cross Below 200 DMA
1 hour, 14 minutes ago


More Technical Analysis News

A Technical AnalysisA RSI
Agilent Technologies is engaged in life sciences, diagnostics and applied chemical markets. Co.'s segments are: Life Sciences and Applied Markets Business, which provides instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products; Diagnostics and Genomics Business, which includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses; and Agilent CrossLab Business, which spans the entire lab with its consumables and services portfolio to improve customer outcomes.

When researching a stock like Agilent Technologies, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from A Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for A stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
A DMAA MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Agilent Technologies (A) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

ABBV Technical Analysis
ABC Technical Analysis
ABMD Technical Analysis
ABT Technical Analysis
AGN Technical Analysis
ALGN Technical Analysis
ALXN Technical Analysis
AMGN Technical Analysis
BAX Technical Analysis
BDX Technical Analysis
More Healthcare companies »

 

A Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.